Drugs / SLV338
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00885989 | May → Dec 2009 | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLV338 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00885989 ↗ |
| Route | Intravenous | “5 - 1000 mg IV” NCT00885989 ↗ |